ARTICLE | Clinical News
Prucalopride: Phase I data
June 22, 2009 7:00 AM UTC
Pooled data from the double-blind Phase I GBR-9 and GBR-10 trials in 32 and 24 healthy volunteers, respectively, showed that Resolor resulted in no clinically relevant differences in blood pressure or...